This inventor holds 3 USPTO granted patents. Top assignee: Children's Medical Center Corporation. Active years: 1993-1997.
Company Filing History:
Years Active: 1993-1997
Title: Eric P Hoffman: Innovator in Muscular Dystrophy Research
Introduction
Eric P Hoffman is a prominent inventor based in Newton, MA (US). He has made significant contributions to the field of genetic research, particularly in the study of muscular dystrophy. With a total of 3 patents to his name, Hoffman's work has advanced the understanding and diagnosis of this debilitating condition.
Latest Patents
Hoffman's latest patents include groundbreaking inventions related to muscular dystrophy. One of his notable patents is focused on probes for and nucleic acid encoding the muscular dystrophy protein. This invention comprises a substantially purified single-stranded nucleic acid sequence capable of hybridizing to a specific region of DNA on a human X chromosome. This region lies between the deletion break point at Xp21.3 and the translocation break point at X;11. The patent also details a 14 kb cDNA corresponding to the complete muscular dystrophy gene and probes produced from it, which are useful in genetic methods for diagnosing muscular dystrophy. Additionally, his work includes antibodies to dystrophin, the protein product of the muscular dystrophy gene, which are valuable in various immunodiagnostic methods for the condition.
Career Highlights
Hoffman is associated with the Children's Medical Center Corporation, where he continues to push the boundaries of research in muscular dystrophy. His innovative approaches have garnered attention in the scientific community and have paved the way for new diagnostic techniques.
Collaborations
Throughout his career, Hoffman has collaborated with esteemed colleagues such as Anthony Monaco and Michel Koenig. These partnerships have further enriched his research and contributed to the advancements in the field of muscular dystrophy.
Conclusion
Eric P Hoffman stands out as a key figure in the realm of genetic research, particularly in muscular dystrophy. His patents and collaborative efforts have significantly impacted the diagnosis and understanding of this condition. His work continues to inspire future innovations in the field.